Opus Genetics, Inc. (IRD) Net Income by Year
Opus Genetics, Inc. reported a net loss of $49.6M in fiscal year 2025. This represents an increase of 13.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $107.6M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Opus Genetics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IRD Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$107.6M | -$49.6M+13.8% | -$57.5M-476.1% | -$10.0M-155.8% | $17.9M+131.6% | -$56.7M-130.3% | -$24.6M-299.1% | -$6.2M+57.1% | -$14.4M+43.2% | -$25.3M-171.8% | -$9.3M+35.3% | -$14.4M+22.3% | -$18.5M-95.0% | -$9.5M-52.6% | -$6.2M+45.1% | -$11.3M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
IRD Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Opus Genetics, Inc. financials
Frequently Asked Questions
What was Opus Genetics, Inc.'s net income in fiscal year 2025?
Opus Genetics, Inc. reported a net loss of $49.6M in fiscal year 2025.
How fast is Opus Genetics, Inc.'s net income growing?
Opus Genetics, Inc. (IRD) net income rose by 13.8% year over year, from -$57.5M to -$49.6M in fiscal year 2025.
What is Opus Genetics, Inc.'s net income over the last twelve months?
Opus Genetics, Inc. (IRD) reported a $107.6M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Opus Genetics, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Opus Genetics, Inc. (IRD) net income went from -$11.3M in fiscal year 2011 to -$49.6M in fiscal year 2025.
What was Opus Genetics, Inc.'s net income in the most recent quarter?
Opus Genetics, Inc. (IRD) reported -$8.1M in net income in Q2 2026. This represents a decrease of 9.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Opus Genetics, Inc. (IRD) reported on that line in every period on record.